European regulator issues positive opinion on lung drug Daxas

04/26/2010 | Wall Street Journal, The

The European Medicines Agency backed Nycomed and Forest Laboratories' application to market lung drug Daxas as maintenance treatment for chronic bronchitis patients with severe chronic obstructive pulmonary disease. European approval would make Daxas the first oral drug in the region for the life-threatening condition.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR